EP
LABU icon

Edgestream Partners’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Edgestream Partners’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-705
Closed -$83.5K – 897
2023
Q2 		$83.5K Sell
705
-1,528
-68% -$190K 0.01% 703
2023
Q1 		$219K Buy
+2,233
New +$303K 0.02% 512

Other funds holding LABU

Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $278B AUM 44.93% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Edgestream Partners's LABU Position: Q3 2023 in Review

Edgestream Partners sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q3 2023, closing a stake of 705 shares — an estimated $83.5K sold.

Edgestream Partners first reported a position in LABU in Q1 2023 and held it in 2 quarters. The position peaked at $219K in Q1 2023. 47 funds tracked by Wall St. Rank hold LABU as of Q3 2023.

  • Edgestream Partners reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q3 2023 after selling out during the quarter.
  • Edgestream Partners sold 705 Direxion Daily S&P Biotech Bull 3X ETF shares in Q3 2023, an estimated $83.5K.
  • Edgestream Partners first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2023 and held it in 2 quarters.
  • Edgestream Partners's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $219K in Q1 2023.
  • 47 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q3 2023.

Based on Edgestream Partners's 13F filing for Q3 2023, filed 15 Nov 2023.